PBLD and breast cancer: Liang et al.85 have demonstrated that circKDM4C significantly inhibits BC proliferation, metastasis, and doxorubicin resistance in vitro and in vivo, thus suggesting that the treatment targeting of the circKDM4C/miR-548p/PBLD axis may be a desirable treatment target of patients with BC.